COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Patients With Superficial Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00318643
Recruitment Status : Completed
First Posted : April 27, 2006
Last Update Posted : August 16, 2018
Information provided by (Responsible Party):
Halozyme Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2010
Actual Study Completion Date : August 2010
Certification/Extension First Submitted : August 13, 2018